354 related articles for article (PubMed ID: 11889721)
1. Assessment of venous leg ulcers: an in-depth discussion of a literature-guided approach.
Kunimoto BT
Ostomy Wound Manage; 2001 May; 47(5):38-49, 52-3. PubMed ID: 11889721
[TBL] [Abstract][Full Text] [Related]
2. Management and prevention of venous leg ulcers: a literature-guided approach.
Kunimoto BT
Ostomy Wound Manage; 2001 Jun; 47(6):36-42, 44-9. PubMed ID: 11890083
[TBL] [Abstract][Full Text] [Related]
3. Best practices for the prevention and treatment of venous leg ulcers.
Kunimoto B; Cooling M; Gulliver W; Houghton P; Orsted H; Sibbald RG
Ostomy Wound Manage; 2001 Feb; 47(2):34-46, 48-50. PubMed ID: 11235498
[TBL] [Abstract][Full Text] [Related]
4. Emerging treatment options for venous ulceration in today's wound care practice.
Kistner RL; Shafritz R; Stark KR; Warriner RA
Ostomy Wound Manage; 2010 Apr; 56(4):E1-11. PubMed ID: 20424289
[TBL] [Abstract][Full Text] [Related]
5. Improved healing rates for chronic venous leg ulcers: pilot study results from a randomized controlled trial of a community nursing intervention.
Edwards H; Courtney M; Finlayson K; Lewis C; Lindsay E; Dumble J
Int J Nurs Pract; 2005 Aug; 11(4):169-76. PubMed ID: 15985095
[TBL] [Abstract][Full Text] [Related]
6. Care of venous leg ulcers.
Falanga V
Ostomy Wound Manage; 1999 Jan; 45(1A Suppl):33S-43S; quiz 44S-45S. PubMed ID: 10085974
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of elastase in acute wounds of healthy aged humans and chronic venous leg ulcers are associated with matrix degradation.
Herrick S; Ashcroft G; Ireland G; Horan M; McCollum C; Ferguson M
Lab Invest; 1997 Sep; 77(3):281-8. PubMed ID: 9314951
[TBL] [Abstract][Full Text] [Related]
8. Leg ulcers - causes and management.
Dean S
Aust Fam Physician; 2006 Jul; 35(7):480-4. PubMed ID: 16820817
[TBL] [Abstract][Full Text] [Related]
9. Leg ulcers: a practical approach to the leg ulcer patient.
Ennis WJ; Meneses P
Ostomy Wound Manage; 1995 Aug; 41(7A Suppl):52S-62S; discussion 63S. PubMed ID: 7669200
[TBL] [Abstract][Full Text] [Related]
10. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
11. Venous leg ulcers in the elderly patient: associated stress, social support, and coping.
Snyder RJ
Ostomy Wound Manage; 2006 Sep; 52(9):58-66, 68. PubMed ID: 16980730
[TBL] [Abstract][Full Text] [Related]
12. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers.
Sibbald RG; Contreras-Ruiz J; Coutts P; Fierheller M; Rothman A; Woo K
Adv Skin Wound Care; 2007 Oct; 20(10):549-58. PubMed ID: 17906429
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of healing and antimicrobiological effects of herbal therapy on venous leg ulcer: pilot study.
Binić I; Janković A; Janković D; Janković I; Vrucinić Z
Phytother Res; 2010 Feb; 24(2):277-82. PubMed ID: 19610037
[TBL] [Abstract][Full Text] [Related]
14. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
[TBL] [Abstract][Full Text] [Related]
15. Direct triggers for ulceration in patients with venous insufficiency.
Shai A; Halevy S
Int J Dermatol; 2005 Dec; 44(12):1006-9. PubMed ID: 16409265
[TBL] [Abstract][Full Text] [Related]
16. Continuity through best practice: design and implementation of a nurse-led community leg-ulcer service.
Lorimer K
Can J Nurs Res; 2004 Jun; 36(2):105-12. PubMed ID: 15369168
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs.
Davies CE; Hill KE; Newcombe RG; Stephens P; Wilson MJ; Harding KG; Thomas DW
Wound Repair Regen; 2007; 15(1):17-22. PubMed ID: 17244315
[TBL] [Abstract][Full Text] [Related]
18. Ulcer-related problems and health care needs in patients with venous leg ulceration: a descriptive, cross-sectional study.
Heinen MM; Persoon A; van de Kerkhof P; Otero M; van Achterberg T
Int J Nurs Stud; 2007 Nov; 44(8):1296-303. PubMed ID: 16824526
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alfa in nonhealing venous leg ulcers.
Charles CA; Romanelli P; Martinez ZB; Ma F; Roberts B; Kirsner RS
J Am Acad Dermatol; 2009 Jun; 60(6):951-5. PubMed ID: 19344978
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a 6-month treatment with Daflon 500 mg in patients with venous leg ulcers associated with chronic venous insufficiency.
Roztocil K; Stvrtinová V; Strejcek J
Int Angiol; 2003 Mar; 22(1):24-31. PubMed ID: 12771852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
